Disease-Modifying Therapy in Multiple Sclerosis: Mechanism of Action, Risks, and Benefits
Podcast Episode…
New research shows that despite long-standing recommendations that severely mentally ill patients who take antipsychotics undergo annual screening for diabetes and other metabolic disorders, only 30% receive such screening. A recent research letter in JAMA Internal Medicine described a retrospective …
Researchers at Gothenburg University have developed a reference method for standardized measurements that diagnose Alzheimer’s disease decades before symptoms appear. The method has now formally been classified as the international reference method, which means that it will be used as …
Research presented at AAN Sports Concussion Conference this month, suggests that concussion may not significantly impair symptoms or cognitive skills for one gender over another, however, women may still experience greater symptoms and poorer cognitive performance at baseline testing. […
New to the diagnosis of major depressive disorder as of DSM-5 is the specifier “with mixed features.” According to DSM-5, “specifiers provide an opportunity to define a more homogeneous subgrouping of individuals with the disorder who share certain features (e.g., …
A new review published online in American Journal of Neuroradiology highlights the concept that cognitive decline can be identified early and prevented by applying quantitative brain imaging techniques. [More]…
According to a study in PLOS One journal, there is often a substantial delay before diagnosis and treatment initiation of patients with bipolar disorder. Researchers sought to investigate factors associated with the delay before diagnosis of bipolar disorder and the …